338 related articles for article (PubMed ID: 28951419)
1. Group A streptococcal pharyngitis: Immune responses involved in bacterial clearance and GAS-associated immunopathologies.
Soderholm AT; Barnett TC; Sweet MJ; Walker MJ
J Leukoc Biol; 2018 Feb; 103(2):193-213. PubMed ID: 28951419
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of IgG specific antimyosin antibodies in acute rheumatic fever (ARF): differential profiles of antibodies to myosin and soluble myocardial antigens in ARF, acute glomerulonephritis and group A streptococcal pharyngitis.
Jambotkar SM; Shastry P; Kamat JR; Kinare SG
J Clin Lab Immunol; 1993; 40(4):149-61. PubMed ID: 7707341
[TBL] [Abstract][Full Text] [Related]
3. Immunologic impact of tonsillopharyngitis associated with group A streptococci.
Kaplan EL
Adv Otorhinolaryngol; 2011; 72():129-31. PubMed ID: 21865710
[TBL] [Abstract][Full Text] [Related]
4. Immune response against M protein-conserved region peptides from prevalent group A Streptococcus in a North Indian population.
Gupta VK; Sekhar S; Dhanda V; Toor D; Kumar R; Chakraborti A
J Microbiol Immunol Infect; 2016 Jun; 49(3):352-8. PubMed ID: 25087198
[TBL] [Abstract][Full Text] [Related]
5. Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection.
Ashbaugh CD; Moser TJ; Shearer MH; White GL; Kennedy RC; Wessels MR
Cell Microbiol; 2000 Aug; 2(4):283-92. PubMed ID: 11207585
[TBL] [Abstract][Full Text] [Related]
6. A half-century of streptococcal research: then & now.
Krause RM
Indian J Med Res; 2002 Jun; 115():215-41. PubMed ID: 12440194
[TBL] [Abstract][Full Text] [Related]
7. Salivary specific antibodies in relation to adhesion of Streptococcus pyogenes to pharyngeal cells of patients with rheumatic fever and rheumatic heart disease.
Kumar KS; Ganguly NK; Chandrashekher Y; Anand IS; Wahi PL
Adv Exp Med Biol; 1995; 371A():677-9. PubMed ID: 8526017
[No Abstract] [Full Text] [Related]
8. Controlled human infection for vaccination against Streptococcus pyogenes (CHIVAS): Establishing a group A Streptococcus pharyngitis human infection study.
Osowicki J; Azzopardi KI; Baker C; Waddington CS; Pandey M; Schuster T; Grobler A; Cheng AC; Pollard AJ; McCarthy JS; Good MF; Walker MJ; Dale JB; Batzloff MR; Carapetis JR; Smeesters PR; Steer AC
Vaccine; 2019 Jun; 37(26):3485-3494. PubMed ID: 31101422
[TBL] [Abstract][Full Text] [Related]
9. Protein array profiling of tic patient sera reveals a broad range and enhanced immune response against Group A Streptococcus antigens.
Bombaci M; Grifantini R; Mora M; Reguzzi V; Petracca R; Meoni E; Balloni S; Zingaretti C; Falugi F; Manetti AG; Margarit I; Musser JM; Cardona F; Orefici G; Grandi G; Bensi G
PLoS One; 2009 Jul; 4(7):e6332. PubMed ID: 19623252
[TBL] [Abstract][Full Text] [Related]
10. An Experimental Group A
Rivera-Hernandez T; Carnathan DG; Jones S; Cork AJ; Davies MR; Moyle PM; Toth I; Batzloff MR; McCarthy J; Nizet V; Goldblatt D; Silvestri G; Walker MJ
mBio; 2019 Apr; 10(2):. PubMed ID: 31040243
[TBL] [Abstract][Full Text] [Related]
11. Antibody response to group A streptococci in an epidemic of streptococcal pharyngitis.
Rabinowitz K; Bergner-Rabinowitz S; Ferne M; Fleiderman S; Beck A
J Lab Clin Med; 1977 Sep; 90(3):466-74. PubMed ID: 330784
[TBL] [Abstract][Full Text] [Related]
12. An immunological perspective on rheumatic heart disease pathogenesis: more questions than answers.
Bright PD; Mayosi BM; Martin WJ
Heart; 2016 Oct; 102(19):1527-32. PubMed ID: 27260192
[TBL] [Abstract][Full Text] [Related]
13. A Controlled Human Infection Model of Group A
Osowicki J; Azzopardi KI; McIntyre L; Rivera-Hernandez T; Ong CY; Baker C; Gillen CM; Walker MJ; Smeesters PR; Davies MR; Steer AC
mSphere; 2019 Feb; 4(1):. PubMed ID: 30760615
[TBL] [Abstract][Full Text] [Related]
14. Clinical development strategy for a candidate group A streptococcal vaccine.
Schödel F; Moreland NJ; Wittes JT; Mulholland K; Frazer I; Steer AC; Fraser JD; Carapetis J
Vaccine; 2017 Apr; 35(16):2007-2014. PubMed ID: 28318768
[TBL] [Abstract][Full Text] [Related]
15. A
Rahbari KM; Chang JC; Federle MJ
mBio; 2021 May; 12(3):. PubMed ID: 33947757
[TBL] [Abstract][Full Text] [Related]
16. Circulating immune complexes in patients with uncomplicated group A streptococcal pharyngitis and patients with acute poststreptococcal glomerulonephritis.
Yoshizawa N; Treser G; McClung JA; Sagel I; Takahashi K
Am J Nephrol; 1983; 3(1):23-9. PubMed ID: 6340506
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to streptococcal surface enolase react with human alpha-enolase: implications in poststreptococcal sequelae.
Fontán PA; Pancholi V; Nociari MM; Fischetti VA
J Infect Dis; 2000 Dec; 182(6):1712-21. PubMed ID: 11069244
[TBL] [Abstract][Full Text] [Related]
18. Poststreptococcal Illness: Recognition and Management.
Maness DL; Martin M; Mitchell G
Am Fam Physician; 2018 Apr; 97(8):517-522. PubMed ID: 29671499
[TBL] [Abstract][Full Text] [Related]
19. The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes.
Egesten A; Eliasson M; Johansson HM; Olin AI; Morgelin M; Mueller A; Pease JE; Frick IM; Bjorck L
J Infect Dis; 2007 Mar; 195(5):684-93. PubMed ID: 17262710
[TBL] [Abstract][Full Text] [Related]
20. Immune signature of acute pharyngitis in a Streptococcus pyogenes human challenge trial.
Anderson J; Imran S; Frost HR; Azzopardi KI; Jalali S; Novakovic B; Osowicki J; Steer AC; Licciardi PV; Pellicci DG
Nat Commun; 2022 Feb; 13(1):769. PubMed ID: 35140232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
